Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma

Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma

<p>Abstract</p> <p>Background</p> <p>Although numerous chemotherapeutic agents have been tested, the role of systemic chemotherapy for hepatocellular carcinoma (HCC) has not been clarified. New therapeutic strategies are thus needed to improve outcomes, and we designed...

書誌詳細
主要な著者:	Bang Soo-Mee, Lee Jeong, Park Yeon, Kim Ju, Kim Sun, Kwon Oh, Kwon So, Han Sang, Lee Yuna, Park Se, Cho Eun, Shin Dong, Lee Jae
フォーマット:	論文
言語:	English
出版事項:	BMC 2006-01-01
シリーズ:	BMC Cancer
オンライン･アクセス:	http://www.biomedcentral.com/1471-2407/6/3

類似資料

Capecitabine and cisplatin (XP) combination systemic chemotherapy in heavily pre-treated HER2 negative metastatic breast cancer.
著者:: Jieun Lee, 等
出版事項: (2017-01-01)

Metronomic capecitabine versus doxorubicin in advanced hepatocellular carcinoma
著者:: Gehan Abd Elatti Khedr, 等
出版事項: (2016-06-01)

Docetaxel plus cisplatin is effective for patients with metastatic breast cancer resistant to previous anthracycline treatment: a phase II clinical trial
著者:: Lee Jae, 等
出版事項: (2005-02-01)

Intra-Arterial Chemotherapy with Doxorubicin and Cisplatin Is Effective for Advanced Hepatocellular Cell Carcinoma
著者:: Ming-Chun Ma, 等
出版事項: (2014-01-01)

Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE)
著者:: Min‐Hee Ryu, 等
出版事項: (2023-04-01)

Retrospective analyses of cisplatin-based doublet combination chemotherapy in patients with advanced gastric cancer
著者:: Kim Hyeong, 等
出版事項: (2010-10-01)

Chemotherapy for Metastatic Gastric Cancer
著者:: Sung Eun Kim, 等
出版事項: (2025-01-01)

Acute Aortic Thrombosis Following Capecitabine Chemotherapy in a Patient with Colon Cancer
著者:: Min Kyung Lee, 等
出版事項: (2018-09-01)

Lymphocyte-monocyte ratio at day 14 of first cisplatin-doxorubicin chemotherapy is associated with treatment outcome of pediatric patients with localized osteosarcoma
著者:: Jun Ah Lee, 等
出版事項: (2019-02-01)

Prolonged Endurance Exercise Adaptations Counteract Doxorubicin Chemotherapy-Induced Myotoxicity in Mice
著者:: Insu Kwon, 等
出版事項: (2022-04-01)

Capecitabine Maintenance Chemotherapy in the Treatment of Metastatic Colorectal Cancer: A Meta-Analysis
著者:: Bradley Ashley Gue Ong, 等
出版事項: (2022-04-01)

Identification of a biomarker to predict doxorubicin/cisplatin chemotherapy efficacy in osteosarcoma patients using primary, recurrent and metastatic specimens
著者:: Qiong Ma, 等
出版事項: (2024-11-01)

The results of primary chemotherapy of TS-1/cisplatin regimen in unresectable or metastatic gastric cancer patients
著者:: Jung Hyun Song, 等
出版事項: (2014-06-01)

Olaratumab and doxorubicin for the treatment of metastatic soft tissue sarcoma: a retrospective case series
著者:: Joon Young Hur, 等
出版事項: (2019-06-01)

Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder
著者:: Hyun Hwan Sung, 等
出版事項: (2022-03-01)

gene amplification in patients with metastatic cancer
著者:: Su Jin Lee, 等
出版事項: (2017-09-01)

Real-world efficacy and safety of capecitabine with oxaliplatin in patients with advanced adenocarcinoma of the ampulla of Vater
著者:: Seunghwan Lee, 等
出版事項: (2024-05-01)

Occupational Exposure during Intraperitoneal Pressurized Aerosol Chemotherapy Using Doxorubicin in a Pig Model
著者:: Wongeon Jung, 等
出版事項: (2023-06-01)

Neoadjuvant Bevacizumab Plus Docetaxel/Cisplatin/Capecitabine Chemotherapy in Locally Advanced Gastric Cancer Patients: A Pilot Study
著者:: Deguo Yu, 等
出版事項: (2022-05-01)

Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage
著者:: Kabsoo Shin, 等
出版事項: (2019-12-01)

Capecitabine and temozolomide for metastatic intermediate to high-grade pancreatic neuroendocrine neoplasm: a single center experience
著者:: Sathathone Douangprachanh, 等
出版事項: (2022-11-01)

Switching cisplatin to carboplatin in chemotherapy for metastatic penile cancer in a patient intolerant to cisplatin
著者:: Keita Sekine, 等
出版事項: (2024-11-01)

Maintenance chemotherapy after 6 cycles of platinum-doublet regimen in anthracycline-and taxane-pretreated metastatic breast cancer
著者:: Eun Kyo Joung, 等
出版事項: (2021-01-01)

Cisplatin combined with capecitabine-induced chemotherapy for local nasopharyngeal carcinoma can improve the quality of life and reduce toxic and side effects
著者:: Ying Gao, 等
出版事項: (2021-09-01)

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy
著者:: Kim Dong-Wan, 等
出版事項: (2007-04-01)

Oral Capecitabine Achieves Response in Metastatic Eccrine Carcinoma
著者:: Kristian Larson, 等
出版事項: (2018-01-01)

Assessing the Percent of Necrosis after Neoadjuvant Chemotherapy with 24hr Infusional Cisplatin/3 Days Doxorubicin Intermittent with IfosfamideDoxorubicin for Osteosarcoma
著者:: Mozhgan Aalam Samimi, 等
出版事項: (2014-03-01)

Gemcitabine–cisplatin versus MVAC chemotherapy for urothelial carcinoma: a nationwide cohort study
著者:: Yong Seong Lee, 等
出版事項: (2023-03-01)

Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer: a post hoc analysis of the AXEPT study
著者:: Satoru Iwasa, 等
出版事項: (2023-04-01)

Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study.
著者:: In Sil Choi, 等
出版事項: (2018-01-01)

Pressurized intraperitoneal aerosol chemotherapy with cisplatin and doxorubicin or oxaliplatin for peritoneal metastasis from pancreatic adenocarcinoma and cholangiocarcinoma
著者:: Andrea Di Giorgio, 等
出版事項: (2020-07-01)

CAPECITABINE IN THE TREATMENT OF BRAIN METASTATIC LESION IN PATIENTS WITH BREAST CANCER
著者:: E. A. Moskvina, 等
出版事項: (2015-04-01)

A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database study.
著者:: In Sil Choi, 等
出版事項: (2018-01-01)

Real-world outcomes of adjuvant gemcitabine gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma
著者:: Sora Kang, 等
出版事項: (2022-05-01)

Complex interaction networks of cytokines after transarterial chemotherapy in patients with hepatocellular carcinoma.
著者:: Dong Wook Jekarl, 等
出版事項: (2019-01-01)

Endostar Combined with Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Nasopharyngeal Carcinoma: an Update
著者:: Ting Jin, 等
出版事項: (2018-04-01)

Efficacy of Capecitabine Plus Oxaliplatin Combination Chemotherapy for Advanced Pancreatic Cancer after Failure of First-Line Gemcitabine-Based Therapy
著者:: Kwang Hyun Chung, 等
出版事項: (2017-03-01)

Cisplatin and vinorelbine in the treatment of locally advanced and metastatic non-small cell lung cancer
著者:: Wong, Catherine Mee Ming, 等
出版事項: (2001)

Economic evaluation of third-line neratinib plus capecitabine versus lapatinib plus capecitabine with HER2+ metastatic breast cancer
著者:: Lanqi Ren, 等
出版事項: (2023-08-01)

Milnacipran Has an Antihyperalgesic Effect on Cisplatin-Induced Neuropathy
著者:: Sun Jin Cho, 等
出版事項: (2023-08-01)